COMP <GO>
CVSA vs GHC // OPERATING MARGIN
Covista Inc. (NYSE) VS. Graham Holdings Company (NYSE) • 15-METRIC TALLY: CVSA 11
— GHC 1
▲ OPERATING MARGIN LEADER: CVSA
LAST: $124.33 (-3.44%) • MKT CAP: $4.36B
operating-margins
19.10%
LAST: $1,168.51 (+0.56%) • MKT CAP: $4.92B
operating-margins
4.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVSA VS. GHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVSA | GHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.80% | 3.50% | +11.30 | CVSA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.5x | 18.1x | -5.60 | CVSA | /valuation <GO> |
| Free Cash Flow Yield | 6.60% | 5.59% | +1.01 | CVSA | /fcf-yield <GO> |
| Operating Margin ACTIVE | 19.10% | 4.80% | +14.30 | CVSA | /operating-margins <GO> |
| Net Profit Margin | 13.30% | 6.00% | +7.30 | CVSA | /net-margins <GO> |
| Revenue Growth (YoY) | 12.90% | 2.50% | +10.40 | CVSA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 0.00% | +3.40 | CVSA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.73 | 3.05 | +1.68 | CVSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | CVSA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 43.8 | +8.10 | CVSA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.5x | 15.6x | -0.10 | CVSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.36B | $4.92B | -$561.3M | GHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVSA REV | GHC REV | CVSA GROSS % | GHC GROSS % | CVSA FCF | GHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.79B | $4.91B | 56.9% | — | $287.6M | $275.3M |
| FY 2024 | $1.58B | $4.79B | 55.9% | — | $246.9M | $324.1M |
| FY 2023 | $1.45B | $4.41B | — | — | $126.6M | $259.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVSA // BETA 1.05
GHC // BETA —